How to research a manufacturer across FDA names
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Medical-device intelligence
Research Syva Co., Dade Behring, Inc. in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.
This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.
19 clearance records and 0 recall records in the covered releases, across 1 source company names and 19 product codes. Dated history runs from Mar 27, 2000 to Jul 2, 2001.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 0 | 0 |
| July 2026 | 0 | 0 |
| August 2026 | 0 | 0 |
| September 2026 | 0 | 0 |
| October 2026 | 0 | 0 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| EMIT 2000 DIGOXIN ASSAY, MODEL OSR4H229K011920 · KXT | Syva Co., Dade Behring, Inc. | 510(k) | Jul 2, 2001FDA decision date |
| EMIT 2000 N-ACETYLPROCAINAMIDE ASSAY, MODEL OSR4N229K011620 · LAN | Syva Co., Dade Behring, Inc. | 510(k) | Jun 18, 2001FDA decision date |
| EMIT 2000 QUINIDINE ASSAY, MODEL OSR4Q229K011605 · LBZ | Syva Co., Dade Behring, Inc. | 510(k) | Jun 12, 2001FDA decision date |
| EMIT II PLUS CANNABINOID ASSAY, MODEL OSR9N229K011300 · LDJ | Syva Co., Dade Behring, Inc. | 510(k) | May 17, 2001FDA decision date |
| EMIT II PLUS BENZODIAZEPINE ASSAY, MODEL 0SR9F229K011306 · JXM | Syva Co., Dade Behring, Inc. | 510(k) | May 16, 2001FDA decision date |
| MODIFICATION TO THE EMIT II PLUS PHENCYCLIDINE ASSAY, MODEL OSR9J229K011161 · LCM | Syva Co., Dade Behring, Inc. | 510(k) | May 15, 2001FDA decision date |
| EMIT II PLUS OPIATE ASSAY, MODEL OSR9B229K011289 · DJG | Syva Co., Dade Behring, Inc. | 510(k) | May 15, 2001FDA decision date |
| MODIFICATION TO THE EMIT II PLUS PROPOXYPHENE ASSAY, MODEL OSR9G229K011163 · JXN | Syva Co., Dade Behring, Inc. | 510(k) | May 10, 2001FDA decision date |
| MODIFICATION TO THE EMIT II PLUS METHAQUALONE ASSAY, MODEL OSR9Q229K011164 · KXS | Syva Co., Dade Behring, Inc. | 510(k) | May 10, 2001FDA decision date |
| MODIFICATION TO EMIT 2000 THEOPHYLLINE ASSAY, MODEL OSR 4P229K011166 · KLS | Syva Co., Dade Behring, Inc. | 510(k) | May 10, 2001FDA decision date |
| MODIFICATION TO THE EMIT II PLUS COCAINE METABOLITE ASSAYK011162 · DIO | Syva Co., Dade Behring, Inc. | 510(k) | May 2, 2001FDA decision date |
| EMIT II PLUS ETHYL ALCOHOL ASSAY, MODEL OSR9K229K010960 · DIC | Syva Co., Dade Behring, Inc. | 510(k) | Apr 26, 2001FDA decision date |
| EMIT II PLUS METHADONE ASSAY, MODEL OSRE229K010962 · DJR | Syva Co., Dade Behring, Inc. | 510(k) | Apr 26, 2001FDA decision date |
| EMIT II PLUS BARBITUATE ASSAY, MODEL 0SR9D0229K010934 · DIS | Syva Co., Dade Behring, Inc. | 510(k) | Apr 20, 2001FDA decision date |
| EMIT 2000 GENTAMICIN PLUS ASSAYK010984 · LCD | Syva Co., Dade Behring, Inc. | 510(k) | Apr 20, 2001FDA decision date |
| EMIT 2000 PROCAINAMIDE ASSAY, MODEL OSR4K229K010812 · LAR | Syva Co., Dade Behring, Inc. | 510(k) | Apr 13, 2001FDA decision date |
| EMIT 2000 CARBAMAZEPINE ASSAY, MODEL OSR4F229K010814 · KLT | Syva Co., Dade Behring, Inc. | 510(k) | Apr 13, 2001FDA decision date |
| EMIT 2000 TOBRAMYCIN ASSAY EMIT 2000 TOBRAMYCIN CALIBRATORSK003341 · KLB | Syva Co., Dade Behring, Inc. | 510(k) | Jan 22, 2001FDA decision date |
| SYVA EMIT 2000 THYROXINE ASSAY, CALIBRATORSK000600 · KLI | Syva Co., Dade Behring, Inc. | 510(k) | Mar 27, 2000FDA decision date |
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Build a repeatable clearance search using FDA applicant names, product codes, decision dates, and original records.
Read the guide →FDA dataset:
Last successful check: Nov 22, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.